In vitro testing strategy for assessing the skin sensitizing potential of "difficult to test" cosmetic ingredients.

Before placing a new cosmetic ingredient on the market, manufacturers must establish its safety profile, in particular assessing the skin sensitization potential, which is a mandatory requirement for topical applications. Since the ban on animal testing in Europe, and its extension to many parts of the world, a battery of in vitro tests covering the key steps of the Adverse Outcome Pathway (AOP) for skin sensitization is recommended. To date, three in vitro methods are validated in the OECD guidelines (442C, 442D, 442E), and many others are under validation by OECD (2019) and ECVAM.

Ethoxylated rapeseed oil derivatives as non-ionic adjuvants for glyphosate.

In a study aimed at finding environmentally benign adjuvants for glyphosate, ethoxylates of rapeseed oil and of methylated rapeseed oil were synthesized, with ethylene oxide (EO) content up to 40 and 8 respectively. They had less influence on spray retention by barley shoots than ethoxylated (15 EO) tallow amine (ETA). At 10 g L(-1), ethoxylated rapeseed oil with 30 or 40 EO and ethoxylated methylated rapeseed oil with 6 or 8 EO promoted glyphosate uptake by barley leaves to a greater extent than ETA at the same concentration.

Ethoxylated rapeseed oil derivatives as novel adjuvants for herbicides.

Ethoxylates of rapeseed oil and of methylated rapeseed oil were synthesized and tested as adjuvants for 2,4-D and phenmedipham. Provided they had less than 6 units of ethylene oxide (EO), 1.0 to 10 g litre(-1) ethoxylates in water induced droplet spreading on barley leaves.